EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Rhein Alleviates Cisplatin-Induced Acute Kidney Injury via Downregulation of NOX4-COX2/PGFS Signaling Pathway

Xi Yuan iD, Luosha Long iD, Minghui Wang iD, Wenhao Chen iD, Baien Liang iD, Long Xu iD, Weidong Wang iD, Chunling Li iD

Drug Design, Development and Therapy · 2025-05 · Volume 19 · 4641-4664

DOI: 10.2147/dddt.s515409 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025-05. Verfasst von Xi Yuan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Cisplatin, Acute Kidney Injury, Anthraquinones. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Cisplatin (cis-diamminedichloroplatinum II, CDDP), a widely used chemotherapeutic agent, is clinically limited by nephrotoxicity. Rhein, an anthraquinone from Radix Rhein Et Rhizome, shows nephroprotective potential. This study investigated Rhein's protective effects and mechanisms in CDDP-induced acute kidney injury (AKI).

Methods

Network pharmacology identified active components and target genes of Radix Rhein Et Rhizome. Bioinformatics analysis screened differentially expressed genes and conducted functional enrichment (GO/HALLMARK). Molecular docking and molecular dynamic (MD) simulations confirmed Rhein's binding to target proteins. CDDP-induced AKI mouse models and human proximal tubular epithelial cells (HK2) injury models were established to reveal Rhein's nephroprotective mechanisms. Lewis lung carcinoma (LLC) tumor-bearing mice and human A549 lung cancer cells further validated Rhein's compatibility with CDDP antitumor efficacy.

Results

Network pharmacology revealed 12 bioactive components and 420 potential targets of Radix Rhein Et Rhizome, with Rhein as the core component interacting with 50 cross-validated targets. Protein-protein interaction (PPI) network analysis prioritized 16 hub genes functionally enriched in oxidative stress (GO) and inflammatory/apoptotic pathways (HALLMARK). Molecular docking and MD simulations demonstrated Rhein's robust binding stability with NOX4, COX2, and PGFS, indicating multi-target modulation. In vivo, Rhein attenuated CDDP-induced AKI by reducing plasma creatinine, renal KIM-1/NGAL expression, and suppressing tubular apoptosis and inflammation. In vitro, Rhein mitigated CDDP-triggered HK2 cell injury through reducing ROS levels and inhibiting the NOX4-NFκB-COX2/PGFS axis. Notably, Rhein preserved CDDP's tumor-suppressive effects in both LLC-bearing mice and A549 cells.

Conclusion

Rhein protects against CDDP-induced AKI by inhibiting oxidative stress and inflammation through targeting the NOX4-NFκB-COX2/PGFS pathway, without compromising CDDP's antitumor activity. These findings highlight Rhein as a promising adjunctive therapy for CDDP-associated nephrotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinAcute Kidney InjuryAnthraquinonesAnimalsHumansMiceAntineoplastic AgentsSignal TransductionMice, Inbred C57BLDown-RegulationCyclooxygenase 2NADPH Oxidase 4Molecular Docking SimulationMaleDose-Response Relationship, DrugDrug Screening Assays, AntitumorDisease Models, AnimalStructure-Activity RelationshipMolecular Structure

Stichwörter der Autor:innen

acute kidney injurycisplatininflammationoxidative stressrhein

Substanzen

CisplatinrheinAnthraquinonesAntineoplastic AgentsCyclooxygenase 2NADPH Oxidase 4

Autor:innen und Institutionen

  • Department of Physiology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, People's Republic of China.
  • Institute of Hypertension, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, People's Republic of China.
  • Department of Pathophysiology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, People's Republic of China.

ORCID-Profile: Xi Yuan, Luosha Long, Minghui Wang, Wenhao Chen, Baien Liang, Long Xu, Weidong Wang, Chunling Li

Zitieren

APA

Yuan, X., Long, L., Wang, M., Chen, W., Liang, B., Xu, L., Wang, W., & Li, C. (2025). Rhein Alleviates Cisplatin-Induced Acute Kidney Injury via Downregulation of NOX4-COX2/PGFS Signaling Pathway. Drug Design, Development and Therapy, Volume 19, 4641-4664. https://doi.org/10.2147/dddt.s515409

Vancouver

Yuan X, Long L, Wang M, Chen W, Liang B, Xu L, et al. Rhein Alleviates Cisplatin-Induced Acute Kidney Injury via Downregulation of NOX4-COX2/PGFS Signaling Pathway. Drug Design, Development and Therapy. 2025;Volume 19:4641-4664. doi:10.2147/dddt.s515409

BibTeX
@article{Yuan2025,
  author = {Yuan, Xi and Long, Luosha and Wang, Minghui and Chen, Wenhao and Liang, Baien and Xu, Long and Wang, Weidong and Li, Chunling},
  title = {Rhein Alleviates Cisplatin-Induced Acute Kidney Injury via Downregulation of NOX4-COX2/PGFS Signaling Pathway},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  volume = {Volume 19},
  pages = {4641--4664},
  doi = {10.2147/dddt.s515409}
}
Kostenlos starten →